Author Archives: SPRIM GLOBAL INVESTMENTS
R&D SERVICES/CRO
SPRIM Global Investments names Susan Dallabrida as Chief Executive Officer of SPRIM Consultancy
SPRIM Global Investments announces the promotion of Susan Dallabrida, PhD, to Chief Executive Officer of...
Read moreBIOTECH
AUM Biosciences announces closing of $27 million in a “Series A” Round of funding to advance its clinical stage pipeline of precision and targeted cancer therapies
SINGAPORE and NEW YORK, October 12, 2021 – AUM Biosciences (AUM) today announced the successful completion of...
Read moreR&D SERVICES/CRO
Leveraging Next-Gen Tools in Rare Disease Research
The capture of high-quality, accurate and complete datasets in a clinical trial is always of...
Read moreMEDTECH
Fibronostics Raises $8 Million in Series A Financing
NEW YORK & SINGAPORE – August 24, 2020 – Fibronostics, a global company providing non-invasive, algorithmic...
Read moreMEDTECH
Fibronostics Appoints Dr. Stephen A. Harrison to its Board of Advisors
NEW YORK, August 3, 2020 – Fibronostics, a global diagnostics company, providing non-invasive, algorithmic diagnostics to...
Read more